Search
"We analyze health care utilization and cost to the health care system for vancomycin vs daptomycin in the outpatient setting and find that vancomycin results in significantly higher health care utilization and similar cost per course compared with daptomycin in OPAT" Streifel et al (2024).
Comparison of vancomycin and daptomycin cost in OPAT

Abstract:

Vancomycin and daptomycin are frequently used in outpatient parenteral antimicrobial therapy (OPAT). We analyze health care utilization and cost to the health care system for vancomycin vs daptomycin in the outpatient setting and find that vancomycin results in significantly higher health care utilization and similar cost per course compared with daptomycin in OPAT.

Reference:

Streifel AC, Luis K, Nakrani M, Yu D, Sikka MK, Varley CD, Douglass A, Mayer H, Young K, Lewis JS 2nd. Put the Vanc Down, Flip It and Reverse It: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy. Open Forum Infect Dis. 2024 Jul 25;11(8):ofae438. doi: 10.1093/ofid/ofae438. PMID: 39130079; PMCID: PMC11310585.

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey